Safety and Immunogenicity Study of Three Candidate HIV-1 Vaccines, Administered in Combination to Healthy HIV-1 Uninfected Adults

NCT01151319 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

HIV-1 Infections

Interventions

BIOLOGICAL: ChAdV63.HIVconsv low dose.
BIOLOGICAL: ChAdV63.HIVconsv high dose.
BIOLOGICAL: pSG2.HIVconsv
BIOLOGICAL: MVA.HIVconsv
OTHER: Placebo

Sponsor

University of Oxford